| Primary |
| Asthma |
13.0% |
| Dysmenorrhoea |
13.0% |
| Arthralgia |
11.7% |
| Back Pain |
7.8% |
| Haemorrhoids |
6.5% |
| Diabetes Mellitus |
5.2% |
| Hyperpyrexia |
5.2% |
| Migraine |
3.9% |
| Pain |
3.9% |
| Spondyloarthropathy |
3.9% |
| Anxiety |
2.6% |
| Arthritis |
2.6% |
| Dental Treatment |
2.6% |
| Dyspepsia |
2.6% |
| Hypertension |
2.6% |
| Musculoskeletal Pain |
2.6% |
| Osteoarthritis |
2.6% |
| Pain In Extremity |
2.6% |
| Pyrexia |
2.6% |
| Tonsillitis |
2.6% |
|
| Weight Decreased |
16.7% |
| Cardio-respiratory Arrest |
6.7% |
| Cholestatic Liver Injury |
6.7% |
| Dyspnoea |
6.7% |
| Liver Injury |
6.7% |
| Respiratory Rate Increased |
6.7% |
| Wound Debridement |
6.7% |
| Anaphylactic Shock |
3.3% |
| Appendicitis |
3.3% |
| Atrial Natriuretic Peptide Increased |
3.3% |
| Blood Count Abnormal |
3.3% |
| Blood Glucose Increased |
3.3% |
| Blood Immunoglobulin E Increased |
3.3% |
| Blood Urea Increased |
3.3% |
| Cold Sweat |
3.3% |
| Diabetes Mellitus |
3.3% |
| Drug Abuse |
3.3% |
| Electrocardiogram St Segment Elevation |
3.3% |
| Embolia Cutis Medicamentosa |
3.3% |
| Grand Mal Convulsion |
3.3% |
|
| Secondary |
| Pain |
11.3% |
| Tooth Extraction |
10.2% |
| Myalgia |
9.5% |
| Rhinitis Allergic |
9.5% |
| Osteoarthritis |
8.8% |
| Product Used For Unknown Indication |
7.3% |
| Eczema Asteatotic |
5.1% |
| Furuncle |
5.1% |
| Immunisation |
5.1% |
| Pruritus |
5.1% |
| Periodontitis |
4.4% |
| Procedural Pain |
4.4% |
| Back Pain |
3.3% |
| Spondyloarthropathy |
2.2% |
| Suicide Attempt |
1.8% |
| Arthritis |
1.5% |
| Hypertension |
1.5% |
| Maternal Exposure Timing Unspecified |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Asthma |
1.1% |
|
| Vitamin B12 Decreased |
17.4% |
| Vitamin B12 Deficiency |
13.0% |
| Convulsion |
6.5% |
| Renal Failure Acute |
6.5% |
| Vomiting |
6.5% |
| Appendicitis |
4.3% |
| Blood Count Abnormal |
4.3% |
| Gastrointestinal Haemorrhage |
4.3% |
| Melaena |
4.3% |
| Nausea |
4.3% |
| Rash |
4.3% |
| Shock |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Abdominal Discomfort |
2.2% |
| Abdominal Pain |
2.2% |
| Acute Generalised Exanthematous Pustulosis |
2.2% |
| Application Site Irritation |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Cardio-respiratory Arrest |
2.2% |
| Completed Suicide |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.6% |
| Drug Use For Unknown Indication |
14.0% |
| Rheumatoid Arthritis |
7.7% |
| Arthritis |
6.2% |
| Muscle Spasms |
6.2% |
| Nausea |
5.7% |
| Hypercalcaemia |
5.6% |
| Pain |
5.3% |
| Depression |
4.7% |
| Cellulitis |
4.0% |
| Analgesic Therapy |
3.2% |
| Insomnia |
3.1% |
| Arthralgia |
2.7% |
| Sleep Disorder |
2.7% |
| Headache |
2.5% |
| Hypertension |
2.2% |
| Osteoporosis |
1.9% |
| Contraception |
1.7% |
| Ankylosing Spondylitis |
1.6% |
| Diabetes Mellitus |
1.6% |
|
| Weight Increased |
17.0% |
| Vomiting |
9.6% |
| Pulmonary Embolism |
8.5% |
| Wrong Technique In Drug Usage Process |
6.4% |
| Renal Failure |
5.3% |
| Tachycardia |
5.3% |
| Dental Plaque |
4.3% |
| Pain |
4.3% |
| Soft Tissue Infection |
4.3% |
| Acute Generalised Exanthematous Pustulosis |
3.2% |
| Blindness Unilateral |
3.2% |
| Cough |
3.2% |
| Dehydration |
3.2% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Multiple Sclerosis Relapse |
3.2% |
| Myocardial Infarction |
3.2% |
| Nodule |
3.2% |
| Osteomyelitis |
3.2% |
| Pharmaceutical Product Complaint |
3.2% |
| Pneumonia |
3.2% |
|
| Interacting |
| Pain |
50.0% |
| Product Used For Unknown Indication |
33.3% |
| Prophylaxis |
16.7% |
|
| Renal Failure Acute |
100.0% |
|
